Heart Failure 2016

21 - 24 May 2016, Florence - Italy

Session Details

Poster Session 1: Co-morbidities
Sat 21 May 08:30 - 17:30 Miscellaneous Poster Session Poster Area -

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30P306Recording of clinical characteristics of hospitalized patients due to heart failure and comparison between age groups with emphasis to the elderlyEmmanuil LAMBROGIANNAKIS (Heraklion (Iraklio-Kriti), Greece)
08:30P307Azilsartan medoxomil improves central and brachial 24-h ambulatory blood pressure control in diabetic hypertensive patientsZhanna D KOBALAVA (Moscow, Russian Federation)
08:30P308Clinical implications of coronary artery disease after transcatheter aortic valve implantation in patients with severe aortic stenosis.Erika MUNOZ GARCIA (Malaga, Spain)
08:30P309Cerebrovascular and other concomitant diseases in female and male patients with heart failure-results from CRO-HF RegistryDuska GLAVAS (Split, Croatia)
08:30P310Diabetes in recipients after heart transplantationMaria SIMONENKO (Saint-Petersburg, Russian Federation)
08:30P311Hyponatremia in heart failure: clinical correlations and prognosisCamelia Cristina DIACONU (Bucharest, Romania)
08:30P312Prevalence and prognosis of different patterns of cardiohepatic syndrome in acute decompensated heart failureAnzhela SOLOVEVA (Moscow, Russian Federation)
08:30P313Impact of malnutrition on long-term mortality in outpatients with chronic heart failure.Juan Luis BONILLA PALOMAS (Cordoba, Spain)
08:30P314Erectile dysfunction in patients with heart failure, a matter of ejection fraction?Pablo MERAS COLUNGA (Madrid, Spain)
08:30P315Validity of an algorithm in implantable devices for the diagnosis of sleep-disordered breathing in heart failureSimon PEARSE (London, United Kingdom)
08:30P316Sleep-disordered breathing is associated with impaired cardiac sympathetic innervation and incrementally predicts prognosis in heart failure patientsStefania PAOLILLO (Naples, Italy)
08:30P317Unpublished association between iron deficiency and left heart filling pressure in patients diagnosed of chronic heart failure and reduced ejection fractionJose Antonio ORTIZ DE MURUA (Zamora, Spain)
08:30P318Chronic heart failure in diabetic patients with low extremity artery disease with/without anemiaEvgeniya SHALAEVA (Tashkent, Uzbekistan)
08:30P319Use of two-dimensional "2D" stain imaging for early detection of ironoverload cardiomyopathy in polytransfused patients.Fakher MROUA (Sfax, Tunisia)
08:30P320Iron deficiency and risk of early readmission after an admission for acute heart failure.Ingrid CARDELLS BELTRAN (Castellnovo, Spain)
08:30P321Assessment of myocardial iron in heart failure before and after correction of functional iron deficiency by intravenous iron therapy with ferric carboxymaltose using cardiac magnetic resonance ImagingAnja SANDEK (Goettingen, Germany)
08:30P322Iron status in patients with heart failure with reduced ejection fraction with ischaemic versus non-ischaemic aetiology.Marcin Dariusz DROZD (Wroclaw, Poland)
08:30P323Cardiorenal relations in patients with septic conditionsTatiana GETIYA (Moscow, Russian Federation)
08:30P324Circadian blood pressure profile in patients with ischemic chronic heart failure with renal dysfunctionDmytro LASHKUL (Zaporizhzhya, Ukraine)
08:30P325Validated-internally kidney protection program (vkpp) scoring system as a predictor of worsening renal function among hospitalized acute decompensated heart failure patientsVebiona SURANGGAYUDHA (Jakarta Barat, Indonesia)
08:30P326Short-term rosuvastatin therapy reduced risk of contrast-induced acute kidney injury in patients with delayed percutaneous coronary interventionSvetlana VILLEVALDE (Moscow, Russian Federation)
08:30P327Incidence and outcomes of contrast-induced acute kidney injury in patients with elective percutaneous interventionSvetlana VILLEVALDE (Moscow, Russian Federation)
08:30P328Hemodynamic predictors of plasma NGAL concentrations and its response to interventionJohn David PARKER (Toronto, Canada)
08:30P329Demographic and clinical outcomes of patients admitted for acute decompensated heart failure (adhf) with worsening renal function(wrf) in a district general hospital in malaysiaPatrick TIAU (Cheras, Malaysia)
08:30P330In patients with CHF creatinine-based measures of GFR in response to acute intervention are directionally opposite to those obtained with inulin and cystatin-cJohn David PARKER (Toronto, Canada)
08:30P331The role of urinary NGAL in acute heart failureMarcela DANKOVA (Bratislava, Slovak Republic)
08:30P332Cancer treatment-related left ventricular dysfunction: retrospective evaluation of a small group of patient treated with ivabradineMatteo SAROCCHI (Santa Margherita Ligure, Italy)
08:30P333Echocardiographic indicators of left and right ventricular diastolic dysfunction in cancer patients complaining of an excessive fatigueMaciej ZECHOWICZ (Olsztyn, Poland)
08:30P334Wasting is not an independent risk factor of mortality in chronic heart failure patients with type 2 diabetes mellitusJacek Tomasz NIEDZIELA (Zabrze, Poland)
08:30P335Effect of trimetazidine on exercise capacity and muscle strength in patients with HFrEFGiuseppe CAMINITI (Rome, Italy)
08:30P336Breast cancer chemotherapy-induced cardiotoxicity; a 10-year observation.Jagdeep Singh Surmukh SINGH (Dundee, United Kingdom)